Radiopharm Theranostics (ASX:RAD) FCF Yield % : -156.12 (As of May. 24, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Radiopharm Theranostics's Trailing 12-Month Free Cash Flow is A$-24.40 Mil, and Market Cap is A$15.19 Mil. Therefore, Radiopharm Theranostics's FCF Yield % for today is -156.12%.

The historical rank and industry rank for Radiopharm Theranostics's FCF Yield % or its related term are showing as below:

ASX:RAD' s FCF Yield % Range Over the Past 10 Years
Min: -182.34 Med: 0 Max: 0
Current: -156.12

ASX:RAD's FCF Yield % is ranked worse than
89.96% of 1554 companies
in the Biotechnology industry
Industry Median: -14.35 vs ASX:RAD: -156.12

Radiopharm Theranostics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Radiopharm Theranostics FCF Yield % Historical Data

The historical data trend for Radiopharm Theranostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics FCF Yield % Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

FCF Yield %

-91.16

-62.58

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	-61.84	-26.94	-90.99	-63.88	-90.51

Competitive Comparison of Radiopharm Theranostics's FCF Yield %

For the Biotechnology subindustry, Radiopharm Theranostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's FCF Yield % falls into.

Radiopharm Theranostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Radiopharm Theranostics's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-24.733	/	39.51915
	=	-62.58%

Radiopharm Theranostics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-11.773	*	2	/	26.01473
	=	-90.51%

Radiopharm Theranostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Radiopharm Theranostics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines